1. A pharmaceutical composition for inhalation containing an aclidinium form of a dry powder of a pharmaceutically acceptable salt mixed with a pharmaceutically acceptable carrier in the form of a dry powder, which contains a measured nominal dose of aklidinium equivalent to about 200 μg of aklidinium bromide. ! 2. The pharmaceutical composition according to claim 1 in the form of a single dose formulation in the form of a dry powder containing one measured nominal dose of aclidinium, equivalent to about 200 μg of aclidinium bromide. ! 3. The pharmaceutical composition according to claim 1 in the form of a multidose formulation in the form of a dry powder, intended for administration using a multidose inhalation device for dry powder, which is calibrated to ensure the introduction of a measured nominal dose of aklidinium equivalent to about 200 μg of aklidinium bromide. ! 4. The pharmaceutical composition according to one of the preceding paragraphs, in which the pharmaceutically acceptable salt of aclidinium is aclidinium bromide. ! 5. The pharmaceutical composition according to claim 1, wherein the pharmaceutically acceptable carrier is lactose particles. ! 6. The pharmaceutical composition according to claim 1, in which the mass ratio of aclidinium and carrier is from 1:50 to 1: 150. ! 7. The pharmaceutical composition according to claim 6, in which the mass ratio of aclidinium and carrier is from 1: 100 to 1: 150. ! 8. The pharmaceutical composition according to claim 1, in which the average particle diameter of aklidinium is 2-5 microns. ! 9. The pharmaceutical composition according to claim 1, in which the carrier particles are characterized by a d10 value of 90-160 μm, a d50 value of 170-270 μm, and a d90 value of1. Фармацевтическая композиция для ингаляции, содержащая аклидиний форме сухого порошка фармацевтически приемлемой соли в смеси с фармацевтически приемлемым носителем в форме сухого порошка, которая содержит отмеренную номинальную дозу аклидиния, экв
